ID
33820
Beschrijving
A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01718145
Link
https://clinicaltrials.gov/show/NCT01718145
Trefwoorden
Versies (1)
- 02-01-19 02-01-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
2 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis C Virus Infection NCT01718145
Eligibility Hepatitis C Virus Infection NCT01718145
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Patients Have
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0030705
- UMLS CUI [1,2]
- C3539897
Beschrijving
Liver carcinoma
Datatype
boolean
Alias
- UMLS CUI [1]
- C2239176
Beschrijving
HBV coinfection | HIV coinfection
Datatype
boolean
Alias
- UMLS CUI [1]
- C2242656
- UMLS CUI [2]
- C4062778
Beschrijving
Severe complication | Complication Uncontrolled
Datatype
boolean
Alias
- UMLS CUI [1]
- C3495031
- UMLS CUI [2,1]
- C0009566
- UMLS CUI [2,2]
- C0205318
Similar models
Eligibility Hepatitis C Virus Infection NCT01718145
- StudyEvent: Eligibility
C3494965 (UMLS CUI [1,2])
C0599755 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0599755 (UMLS CUI [3,1])
C0277556 (UMLS CUI [3,2])
C0919936 (UMLS CUI [1,2])
C3827727 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0279030 (UMLS CUI [2,2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C3274571 (UMLS CUI [3,3])
C3539897 (UMLS CUI [1,2])
C4062778 (UMLS CUI [2])
C0009566 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])